The Efficacy and Safety of Fang yi Qing Feng Shi Granules in Subjects With Rheumatoid Arthritis
Clinical trial NCT02029599 · COMPLETED
Trial details
- NCT number
- NCT02029599
- Sponsor
- Maoxiang Group Jilin Pharmaceutical Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-03-01
- Primary completion
- 2015-08-01
- Enrollment
- 240
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.